The comparison of platelet activity between patients with patent vs. occluded coronary artery bypass grafts

Thrombosis Research

Volumn 120, Issue 4, 2007, Pages 523-529

  Osmancik, Pavel P ^a   Bednar, Frantisek ^a   Móciková, Heidi ^b   Stros, Petr ^a   Jirasek, Karel ^a   Straka, Zbynek ^a   Widimsky, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Aggregometry; Bypass graft; Coronary artery disease; Coronary surgery; Flow cytometry; P selectin; Platelet

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDOBUFEN; INSULIN; ORAL ANTIDIABETIC AGENT; PADGEM PROTEIN; WARFARIN;

ARTICLE; BLOOD SAMPLING; BODY MASS; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SURGERY; CORONARY ARTERY THROMBOSIS; DIABETES MELLITUS; FLOW CYTOMETRY; GRAFT OCCLUSION; GRAFT PATENCY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEUKOCYTE COUNT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; TREATMENT OUTCOME;

AGED; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; VASCULAR PATENCY;

EID: 34548668628     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.12.017     Document Type: Article

References (26)

1. Weintraub W.S., Clements Jr. S.D., Crisco L.V., et al. Twenty-year survival after coronary artery surgery: an institutional perspective from Emory University. Circulation 107 (2003) 1271-1277
2. Motwani J.G., and Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97 (1998) 916-931
3. Parolari A., Alamanni F., Polvani G., et al. Meta-analysis of randomized trials comparing off-pump with on-pump coronary artery bypass graft patency. Ann Thorac Surg 80 (2005) 2121-2125
4. Fuster V., and Vorchheimer D.A. Prevention of atherosclerosis in coronary-artery bypass grafts. N Engl J Med 336 (1997) 212-213
5. Sabik III J.F., Lytle B.W., Blackstone E.H., et al. Does competitive flow reduce internal thoracic artery graft patency?. Ann Thorac Surg 76 (2003) 1490-1496 discussion 1497
6. Okrainec K., Platt R., Pilote L., et al. Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials. J Am Coll Cardiol 45 (2005) 177-184
7. Gawaz M.N.F., and Schomig A. Evaluation of platelet membrane glycoproteins in coronary artery disease. Circulation 99 (1999) e1
8. Michelson A.D. Platelet function testing in cardiovascular diseases. Circulation 110 (2004) e489-e493
9. Nikolsky E.M.R., Grines C.L., Turco M., Cox D.A., Tcheng J.E., Brodie B.R., et al. Higher baseline platelet count predicts reinfarction and death in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. Circulation 112 Suppl II (2005) 695
10. Tschoepe D., Schultheiss H.P., Kolarov P., et al. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 88 (1993) 37-42
11. Kabbani S.S., Watkins M.W., Ashikaga T., et al. Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 104 (2001) 181-186
12. Markovitz J.H., Roubin G.S., Parks J.M., et al. Platelet activation and restenosis after coronary stenting: flow cytometric detection of wound-induced platelet activation. Coron Artery Dis 7 (1996) 657-665
13. Straka Z., Widimsky P., Jirasek K., et al. Off-pump versus on-pump coronary surgery: final results from a prospective randomized study PRAGUE-4. Ann Thorac Surg 77 (2004) 789-793
14. Widimsky P., Straka Z., Stros P., et al. One-year coronary bypass graft patency: a randomized comparison between off-pump and on-pump surgery angiographic results of the PRAGUE-4 trial. Circulation 110 (2004) 3418-3423
15. Michelson A.D. Flow cytometry: a clinical test of platelet function. Blood 87 (1996) 4925-4936
16. www.acc.org. ACC/AHA 2004. Guideline update for coronary artery bypass graft surgery (2004)
17. Goldman S., Copeland J., Moritz T., et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study. Circulation 80 (1989) 1190-1197
18. McEnany M.T., Salzman E.W., Mundth E.D., et al. The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts. J Thorac Cardiovasc Surg 83 (1982) 81-89
19. Damp J., Zhao D.X., Greelish J., et al. Intra-operative completion angiography after CABG with immediate percutaneous or surgical revision of defects: one year experience from the Vanderbilt hybrid catheterization and operating room. Circulation 114 (2006) II-429 (Suppl.)
20. van Brussel B.L., Plokker H.W., Voors A.A., et al. Progression of atherosclerosis after venous coronary artery bypass graft surgery: a 15-year follow-up study. Cathet Cardiovasc Diagn 41 (1997) 141-150
21. Xydas S., Rosen R.S., Pinney S., et al. Reduced myocardial blood flow during left ventricular assist device support: a possible cause of premature bypass graft closure. J Heart Lung Transplant 24 (2005) 1976-1979
22. Sharma G.V., Khuri S.F., Josa M., et al. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency. Circulation 68 (1983) II218-II221
23. Davi G., Gresele P., Violi F., et al. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. Circulation 96 (1997) 69-75
24. Lim H.S., Blann A.D., and Lip G.Y. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention. Circulation 109 (2004) 2524-2528
25. Mathew V., Gersh B.J., Williams B.A., et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 109 (2004) 476-480
26. Schwartz L., Kip K.E., Frye R.L., et al. Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 106 (2002) 2652-2658